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ABSTRACT
The H30Rx subclade of Escherichia coli ST131 is a clinically important, globally dispersed pathogenic lineage that typically
displays resistance to fluoroquinolones and extended spectrum β-lactams. Isolates EC233 and EC234, variants of ST131-
H30Rx with a novel sequence type (ST) 8196, isolated from unrelated patients presenting with bacteraemia at a Sydney
Hospital in 2014 are characterised here. EC233 and EC234 are phylogroup B2, serotype O25:H4A, and resistant to
ampicillin, amoxicillin, cefoxitin, ceftazidime, ceftriaxone, ciprofloxacin, norfloxacin and gentamicin and are likely
clonal. Both harbour an IncFII_2 plasmid (pSPRC_Ec234-FII) that carries most of the resistance genes on an IS26
associated translocatable unit, two small plasmids and a novel IncI1 plasmid (pSPRC_Ec234-I). SNP-based phylogenetic
analysis of the core genome of representatives within the ST131 clonal complex places both isolates in a subclade
with three clinical Australian ST131-H30Rx clade-C isolates. A MrBayes phylogeny analysis of EC233 and EC234
indicates ST8196 share a most recent common ancestor with ST131-H30Rx strain EC70 isolated from the same hospital
in 2013. Our study identified genomic hallmarks that define the ST131-H30Rx subclade in the ST8196 isolates and
highlights a need for unbiased genomic surveillance approaches to identify novel high-risk MDR E. coli pathogens that
impact healthcare facilities.
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Introduction
Resistance to last resort antibiotics severely restricts
treatment options for infections caused by extra-intes-
tinal pathogenic Escherichia coli (ExPEC) lineages such
as sequence type (ST) 131 [1,2]. Although E. coli ST131
is most frequently reported from human infections,
isolates have been recovered from food-producing ani-
mals, mammals, birds, cats, dogs, sheep, agriculture/
horticulture, water and soil [3–7]. ST131 is a globally
dominant, pandemic and multi-drug resistant (MDR)
lineage, associated with both community-acquired
(CA) and hospital-acquired (HA) bloodstream infec-
tions (BSIs) [8–12]. It comprises three major ancestral
clades (A, B and C), with clade C representatives pre-
dominating clinical ST131 isolates globally [13–18].
Interclade diversity is primarily attributed to recombi-
nation events that have shaped representative genomes
[15]. Isolates clustering in these three clades are charac-
terized by the presence of specific type I fimbrial adhe-
sin gene (fimH) alleles, and hence are widely
recognized as ST131 -A/H41, -B/H22 and -C/H30.
Clade C is predicted to have originated from a single
progenitor prior to 2000 and diverged into three dis-
tinct sub-clades -C0, C1 and C2. ST131 sub-clades
C1 and C2 carry diverse IncF plasmids and often
host genes that render critically important antibiotics
ineffective [2,13,16,19]. Strains in subclade C2 are fre-
quently extensively drug-resistant (defined as
H30Rx), and characterized by the presence of IncF2:
A1:B plasmid replicons with a blaCTX-M-15 gene encod-
ing extended-spectrum β-lactamase. Subclade C1 iso-
lates carry IncF1:A2:B20 plasmids and are usually not
associated with blaCTX-M-15 [14,19]. Insertion element
ISEcp1 mobilizes blaCTX-M-15 and is commonly ident-
ified adjacent to it on IncF2:A1:B plasmid replicons
in the H30Rx subclade. Occasionally the ISEcp1-
blaCTX-M-15 module is also located on chromosomes
of highly resistant H30Rx/subclade C2 strains [15,16].
Fluoroquinolone resistance is another defining feature
of ST131 clades C1 and C2 and is attributed to
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chromosomally located alleles gyrA1AB and parC1aAB
[14].
Core genomes of ST131 are highly conserved and
typically comprise ≥3150 genes. Variation in resistance
and virulence profiles are driven by differences in the
accessory genome [20,21]. A recent pangenome analy-
sis of a global collection of 4071 ST131 isolates pre-
dicted the potential for outbreaks caused by close
genetic variants with altered resistance gene cargoes
[14], highlighting the need for meticulous genomic sur-
veillance of this globally dispersed lineage. Close gen-
etic variants of isolates belonging to a specific multi-
locus sequence type (MLST, abbreviated as ST) are
usually grouped as clonal complexes (CC) and com-
prise genetically similar isolates exhibiting a single
change in the allelic profile of genes that define the cen-
tral MLST genotype [20]. At the time of investigation,
the ST131CC comprised 99 different STs in the Enter-
obase database (https://enterobase.warwick.ac.uk/
species/index/ecoli), primarily sourced from human
infections. Emergence of genetic variants of ST131
forming ST131-clonal groups have been reported in
the past [22]; however, to the best of our knowledge,
there are no studies that seek to characterize the differ-
ences and evolutionary relationships among STs resid-
ing within the ST131CC.
Here, we characterized two isolates, EC233 and
EC234, that belong to a novel sequence type –
ST8196, within the ST131CC. The two ST8196 isolates
were collected from unrelated patients treated for bac-
teraemia at Concord Repatriation Hospital in Sydney
in November 2014 [23]. They are both resistant to
third-generation amino-penicillins (ampicillin and
amoxicillin), second and third-generation cephalos-
porins (cefoxitin, ceftazidime and ceftriaxone), quino-
lones (ciprofloxacin and norfloxacin), and the
aminoglycoside antibiotic gentamicin, which estab-
lishes their “extensively drug resistant” [24] status.
We examined the genetic relatedness between these
ST8196 isolates with their closest relatives in the
ST131CC and assessed their evolutionary origin. Our
comprehensive characterization of the two genomes
suggest that ST8196 has likely evolved from represen-
tatives of MDR ST131-H30Rx clones circulating in
Australia.
Material and methods
Bacterial strains and growth conditions
E. coli EC233 and EC234 were sub-cultured on Lyso-
geny Broth (LB) agar plates or broth and grown at
37°C for 18 hours. Genomic DNA was extracted
from overnight broth cultures grown with aeration
on a rotary shaker set at 2500 rpm. Antibiotic suscep-
tibility profiles were generated using the VITEK2 (Bio-
Mérieux) system and interpreted using the European
Committee on Antimicrobial Susceptibility Testing
(EUCAST) breakpoints [25]. Synergy tests were used
to phenotypically confirm production of extended
spectrum beta lactamase (ESBL) enzymes.
Genomic DNA extraction, library preparation
and whole-genome sequencing:
For Illumina HiSeq sequencing, genomic DNA was
extracted using 2 ml of overnight culture with the ISO-
LATE II Genomic DNA kit (Bioline, Australia), follow-
ing the manufacturer’s protocol, and quantified using
the Qubit fluorometer and dsDNA HS Assay kit
(Thermo Fisher Scientific, Australia). Whole-genome
sequencing libraries were prepared from 2 ng of
gDNA using a previously described variation of the
Illumina Nextera protocol [26], and sequenced on Illu-
mina HiSeq 2500 v4 sequencer (Illumina, San Diego,
CA, USA) in PE150 mode.
Isolate EC234 was also sequenced on the PacBio
Single Molecule Real-Time (SMRT) sequencing plat-
form. Genomic DNA for SMRT sequencing was iso-
lated from 1.8 ml of overnight cultures using a
MoBio UltraClean Microbial DNA isolation kit (Qia-
gen, Germany), following the manufacturer’s protocol.
Sequencing was performed at the Ramaciotti Center
for Genomics, University of New SouthWales (Sydney,
Australia). Demultiplexed PacBio long reads were
assembled with the Illumina short reads, using the Uni-
cycler hybrid genome assembler [27] and submitted in
GenBank under accession number WMLE00000000.
The Illumina-only assembly of EC233 is available in
GenBank under accession number SAMN10187599.
Genotypic profiling and genome-wide
comparison of isolates
The new sequence type designation for EC233 and
EC234 were acquired from the Enterobase database
(http://enterobase.warwick.ac.uk/species/index/ecoli).
The resfinder, virulence finder, PlasmidFinder, sero-
type finder and CHtyping databases were accessed via
the Centre of Genomic Epidemiology website (http://
www.genomicepidemiology.org/). Preliminary genome
annotations were generated using an online version of
RASTtk [28]. Putative antimicrobial resistance genes of
interest were confirmed using stand-alone BLASTn
analyses and an in-house database on the high-power
computing cluster available at the University of Tech-
nology Sydney, prior to manual verification of genes
of interest using NCBI-ORF finder. Iterative BLASTn
and BLASTp searches [29–31]were used for confir-
mation of plasmid annotations. Only ORFs showing
>95% sequence similarity across 100% of the query
sequence were considered for further analysis. Figures
comparing BLASTn alignment of genome and plasmid
sequences were generated using BRIG v0.95 [32] set at
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90% lower and 100% upper identity thresholds, Snap-
Gene v3.3.4 (GSL Biotech) and EasyFig version 2.2.2
[33]. Efflux pumps associated with drug resistance in
E. coli were identified using the Resistance Gene Iden-
tifier (RGI) module in the online version of the Com-
prehensive Antibiotic Resistance Database (CARD)
(https://card.mcmaster.ca/). Genomic islands of
EC234 were identified by island-viewer software
(https://www.pathogenomics.sfu.ca/islandviewer/).
Roary [34]was used for Pan Genome analysis.
The binary tree for the presence and absence of
accessory genes were recalculated using the neigh-
bour-joining algorithm and a Jaccard dissimilarity
matrix from the binary data file containing the pres-
ence and absence of gene clusters produced by
Roary. Support values were derived using non-para-
metric bootstrapping with 1000 replicates. This
approach was implemented in a R script [35]. All
figures were edited using Adobe PhotoShop CS6
(Version 13.1.2).
Phylogenetic analysis of ST8196 isolates
The SNP phylogenies of genomes and plasmids were
inferred with parSNP, using the -c and -x flags to
evoke forced alignment across collinear blocks and
recombination filtering to improve accuracy of the
estimated clonal ancestry [36]. The completely closed
and annotated E. coli EC958 ST131
(NZ_HG941718.1) genome [37] was used as a refer-
ence in all SNP based analyses. For the ST131CC phy-
logeny, 72% of the reference genome EC958 was found
conserved among the cohort of 87 genomes and
aligned to calculate phylogenetic inferences. Twenty-
four thousand and eleven variant sites were utilized
in the construction of the phylogenetic tree presented
in Figure 1. For the ST131 and ST8196 phylogeny,
initially 621 ST131 genomes from geographically dis-
tinct areas and an isolation date were downloaded
from Enterobase and aligned using parSNP. Fifty-
four percent of the EC958 reference genome was con-
served among all 621 aligned genomes, containing
4614 variant sites. A maximum-likelihood tree was
constructed using RAxML [38] and the temporal sig-
nal was assessed using TempEst [35]. The evolutionary
history of the genomes was hypothesized using a Baye-
sian Markov chain Monte Carlo method as
implemented in the MrBayes package (version
3.2.7a) [39] on a subset of 148 genomes aligned over
2,780,909 nt and used for phylogenetic inferences pre-
sented in this manuscript. The GTR substitution
model with the gamma model of rate heterogeneity
(4 categories) was utilized. An unconstrained com-
pound gamma-Dirichlet prior was placed on the
branch lengths for the tree and two independent
chains were run for 30 million iterations each. The
convergence was checked using the average standard
deviation of split frequencies (ASDSF) diagnostics
[39]. Phylogenetic tree figures were generated using
FigTree (http://tree.bio.ed.ac.uk/software/figtree/) and
compiled with metadata using online version of iToL
(https://itol.embl.de/) [40].
Results
EC233 and EC234 are representatives of ST8196,
a novel sequence type within ST131-H30Rx
clonal complex
In silicomulti-locus sequence typing (MLST) of EC233
and EC234 led to the establishment of a novel sequence
type, ST8196, within the ST131 clonal cluster. Both
genomes typed as phylogroup B2 and serotype O25:
H4. Of the seven genes used for Achtman E. coli
MLST profiling, ST131 is characterized by allelic var-
iant number 13 of the icd gene encoding iso-citrate
dehydrogenase while ST8196 had allelic variant 912.
Although 99 STs formed the ST131CC in Enterobase,
genome sequences representing 70 STs were available
for downloading at the time of investigation. Our
SNP based phylogenetic tree, with representatives of
70 STs within ST131CC, resolved into three major
clades (I, II and III), akin to ST131 population struc-
ture, with reference strains of ST131 sub-clades A, B
and C [15,41] clustering within clade I, II and III
respectively (Figure 1). Clade III comprised 44 ST
representatives including the ST8196 representatives,
ST131 clade C reference genome S115EC_cladeC-
ESC_CA5436 and EC958. The genotypic profile of
S115EC_cladeC-ESC_CA5436 described previously
[15] confirmed the presence of the fimH30 allele, chro-
mosomal fluoroquinolone-resistant genes gyrA1AB
and parC1aAB and blaCTX-M-15 and a representative
of the H30Rx lineage. Isolate S115EC_cladeC-
ESC_CA5436 was collected from Brisbane in 2011
and EC958 [37] is the closed ST131 reference genome
[15] available in GenBank. Our observations were
based on parSNP alignments, where 72% of the core
genome of EC958 was aligned to infer phylogenetic
relationships and 24,011 variant sites were used in
the construction of the tree.
The ST8196 isolates clustered into a smaller sub-
clade within clade III comprising five genomes (red
box and inset in Figure 1), including Sydney isolate
EC70, S115EC_cladeC-ESC_CA5436 and a ST8189
isolate ESC_RA8813AA. While the ST8196 isolates
EC233 and EC234 in the subclade grouped with
EC70, that was collected in 2013 from Sydney, the
ST8189 isolate grouped with the Brisbane isolate
S115EC_cladeC-ESC_CA5436. Six hundred and sev-
enty-two variant sites were considered in resolving
the ancestral relationships of isolates in this subclade
of five genomes. Using pairwise comparison of regions
of genomes aligned in the parSNP phylogeny analysis,
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EC233 and EC234 had three SNP differences, while
EC70 and EC234 differed by 12 SNPs. The ST8189
representative, ESC_RA8813AA isolated in 2017, had
16 SNP differences with EC234.
The ST8196 isolates, EC233 and EC234, had the
least branch distance to EC70 (ST131) indicating clo-
sest genealogical association. To explore further, we
attempted a time-resolved genealogy on a global
Figure 1. SNP phylogeny of the core genomes of sequence type representatives comprising the ST131 clonal cluster (ST131CC).
Tree scale represents substitution per site. The tree also includes ST131 isolates from our extended collection [33], ST131 reference
genome EC985 and representatives of the three ST131 clades A, B and C [15] highlighted in purple. The red box identifies the sub-
clade with ST8196 isolates EC233 and EC234. Inset magnifies the subclade highlighted in the red box to better resolve the branch-
ing pattern and associated clade confidence scores. Clades I, II and III represent the three major clades in which the different STs
within the ST131CC cluster.
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collection of ST131 genomes and the ST8196 isolates.
Our objective was to identify the origin of ST8196 gen-
omes by determining ancestral relationships with
ST131 genomes circulating locally in Australia and in
geographically distinct regions, which remained uni-
dentified in the previous phylogeny analysis (Figure
1) owing to any unintended bias imposed by the selec-
tion of ST131 genomes. TempEst [42] analysis of
aligned regions from 621 ST131 genomes (retrieved
from the Enterobase database, 30th May 2019)
included in a parSNP analysis, indicated that the coeffi-
cient of correlation between time and substitutions was
0.1 posing a challenge to select an appropriate molecu-
lar clock from the available list of models. Therefore,
we constructed an unrooted phylogenetic tree with
MrBayes in order to investigate the genealogy of
these isolates. The ASDSF calculated from the two
independent chains in MrBayes was 0.004, indicating
that the chains had converged on the same posterior
distribution of tree topologies. MrBayes analysis of a
subset of 148 genomes (representing the widest geo-
graphical distribution for the ST131 genomes depos-
ited in Enterobase), together with all isolates in our
collection and the ST8196 genomes (File S1, S2),
revealed a single subclade of seven genomes (Figure 2
(A) and Figure S2) which were closely related to
EC233 and EC234. The subclade comprised three iso-
lates from Australia and two from the United States
collected between 2011 and 2015 from human (blood
or urine) specimens. The probability scores for resol-
ution of subclades (displayed as node values) were 1,
indicating 100% confidence in the splits. Based on
branch distances between isolates in the subclade high-
lighted as Figure 2(A), the ST8196 representatives
EC233 and EC234 were most closely related to ST131
isolate from Sydney (EC70 collected in 2013). EC70
was collected from Concord Hospital in Sydney in
the course of sample collection for this study [23].
The other two Australian ST131 stains in the subclade,
ESC_PA1114AA and ESC_CA5436AA were collected
from Brisbane, Australia. These Australian isolates in
the subclade clustered with two ST131 genomes from
the USA, ESC_FA7278AA collected from urine speci-
men of a patient in 2013 and ESC_GA1863AA, col-
lected in 2015 from a human blood specimen.
Genotypic profiling of ST131 and ST8196
isolates that cluster together suggest major
differences are within accessory regions of the
genomes
All seven isolates in the subclade (Figure 2(A)) had a
O25:H4 serotype, H30 fimH type, 40–30 CH type, car-
ried the same chromosomal parC (S80I, E84V) and
gyrA(S83L, D87N) mutations (known to confer fluoro-
quinolone resistance) and blaCTX-M-15 which are fea-
tures that define the H30Rx clonal lineage of ST131
[15,16]. In addition, they share a common pool of viru-
lence-associated genes, including iha (encoding adher-
ence protein), iss (increased serum survival gene,
supporting immune evasion) and sat (secreted auto-
transporter toxin) (Figure 2(B)). Three isolates also
carry one (ESC_PA1114AA_AS, ESC_FA7278AA_AS)
or two copies (EC234_ST8196) of the acid neutraliz-
ation and survival gene, gad, encoding glutamate dec-
arboxylase. Isolate ESC_FA7278AA_AS from the
United States additionally carries cnf1 (cytotoxic
necrotising factor) and senB (plasmid-encoded entero-
toxin), genes that are absent in the Australian isolates.
A comparison of the chromosomally located efflux
pumps commonly associated with drug resistance in
E. coli also indicated identical profiles in isolates
EC233_ST8196, EC234_ST8196 and EC70_ST131
(File S3A). Major differences in ST8196 and ST131
genomes were identified in the acquired resistance
gene pool and plasmid profiles as presented in details
in Figure 2(B), indicating contribution of laterally
acquired genes in the emergence of ST8196.
A pairwise BLASTn alignment (Figure 2(C)) of the
six closely related genomes with EC234_ST8196
revealed >98% sequence identity over the length of
the genomes (Figure 2(C)). Major differences were
noticed in sections of the BLAST rings (beyond the
5MB coordinate) where smaller contigs of the partially
closed EC234 genome, comprising the four closed plas-
mids and the four additional contigs were present. The
innermost circle (solid light pink colour) in Figure 2(C)
represents an alignment of EC234 with EC233_ST8196
and revealed >99.9% identity over the entire length of
the genomes, including the accessory regions. Gaps
around genomic coordinates 1.3MB and 1.4MB and
beyond 5MB in the yellow BLAST ring, representing
EC70_ST131, indicated regions of difference with
EC234_ST8196. Annotation of genes between 1.3MB
and 1.4MB in EC234 indicated presence of phage
associated genes, while regions beyond 5MB comprised
plasmid associated genes.
Genomic islands (GI) defined on the basis of regions
of differential codon usage [43] in the partially closed
EC234 genome are indicated as yellow radiating lines
inside the BLASTn rings in Figure 2(C). All isolates
included in the pairwise BLASTn analysis, irrespective
of the country of isolation, revealed near identity across
GIs in EC234 indicating relative conservation of these
loci. Gene content of these regions (File S3B) primarily
comprises mobile element associated genes, hypotheti-
cal genes and some regulatory protein-encoding genes,
except regions around genomic coordinates 1.62Mb
and 1.9MB (File S3B) which houses the type 1 fimbrial
operon recombinase genes, fimB and fimE, in EC234
(File S3B). The fibrillar regulatory genes control
phase variation in uro-pathogenic E. coli and are
located in a well-known variable region of the E. coli
genome and are associated with the differential
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Figure 2. Pangenome analysis of isolates that clustered closely in a MrBayes analysis (Files S1 and S2). A. Magnified view of the
subclade containing ST8196 isolates and other closely related ST131 genomes identified in MrBayes analysis presented in sup-
plementary file S2. B. Genotypic feature that characterize isolates in the subclade presented in section A. Except parC which is high-
lighted with an asterisk (*), all genes listed in the “Resistance genes” column are known to be laterally acquired. C. BLASTn
alignment (using 90% lower and 100% upper identity cutoffs) of 6 genomes against the partially completed EC234_ST8196 gen-
ome. The inner radiating bars indicate the location of genomic islands in EC234, as predicted by the SIGI-HMM module of island-
viewer software. D. Graphical overview of distribution of genes that represent the core and accessory genomes of the isolates in
Roary. (Core genes = genes present in 99% <= strains < = 100%), (Soft core genes = genes present in 95% <= strains < 99%, shell
genes = genes present in 15% <= strains < 95%), Cloud genes (genes present in 0% <= strains < 15%). E. Genome clustering and
the pangenome matrix of 8 genomes (including the outgroup, ESCFA6284_FA). Numbers at the node of the tree indicate bootstrap
values.
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transcriptional regulation of pathogenic factors in
specific E. coli strains [44].
Pangenome analysis of ST131 subclade with
ST8196
Roary [34] was used to map the core-genome and
accessory genome content of the seven closely related
isolates. ESCFA6284AA, collected from a human
blood sample in the USA in 2015 was included as an
outgroup. Based on ≥95% amino acid sequence iden-
tity and MCL clustering (Markov clustering) of pep-
tides encoded by open reading frames, 5953 clusters
constituted the pangenome of all eight isolates, of
which 4527 (Figure 2(D)) clusters comprised the
hard-core of the genomes. In pan-genome analysis,
core genome content is often divided into hard-core
and soft-core, with hard-core gene clusters expected
to be present in all gnomes while gene clusters consti-
tuting soft-core present in ≥95% genomes. The acces-
sory genome content was divided into two subsets,
the “shell” (815) and the “cloud” (611). “Shell” genes
represent a pool of shared accessory genes present in
the majority of genomes analysed, while “cloud”
genes comprise unique clusters present in at least 1
genome in the cohort. Our analysis indicated that
4663 gene clusters were present in at least seven of
the eight genomes (File S4), while the variable pool of
accessory genes comprised 611 clusters. Isolate ESC_-
CA5436AA, clearly had the most variable subset of
unique gene clusters (Figure 2(E), File S4). Clustering
of genomes based on the presence and absence of
accessory genes (Figure 2(E)) indicate that major
differences between ST8196 (EC234 and EC233) and
ST131 genomes were in the accessory gene content.
Combining datasets generated in pangenome analysis
(based on amino acid identity of predicted ORFs)
with whole-genome SNP based phylogeny analyses, it
is evident that major differences between Australian
ST131-H30Rx subclade and the ST8196 isolates,
EC234 and EC233 (Figure 2(E,A)), were in the acces-
sory gene pool.
Gene clusters in the accessory genome pool primar-
ily consisted of plasmid associated genes, resistance
genes and hypotheticals. Co-relating pan-genome
analysis outputs with genotype profiling data, EC233
and EC234 had three typeable plasmid replicons, an
IncFII plasmid, an IncI1 plasmid and a ColBS512-
like plasmid. The IncI1 and ColBS512-like plasmid
replicons were unique to the two ST8196 isolates and
were not identified in any of the closely related
ST131 genomes selected from MrBayes analysis. How-
ever, ColBS512-like plasmid has been identified in
other ST131 isolates [33], and the replicon was ident-
ified in FA6284AA_AS_ST131 the outgroup included
in our Roary analysis (Figure 2(B)). All 5 closely related
ST131 genomes selected via the MrBayes analysis had
IncFIA, IncFII and IncFIB replicons. Isolate
PA1114AA_AS, an ST131 isolate collected from BSI
of a patient in Brisbane, Australia additionally carried
an IncX1 plasmid.
Plasmids in EC234_ST8196
Unicycler hybrid assembly of long and short-read
sequences of EC234 resolved the genome into nine
contigs, including a 5.09Mb contig representing a
major portion of the chromosome, 4 closed plasmids,
and 4 additional contigs which likely form parts of
the chromosome. Contig 2 typed as a 92,955nt IncI1
(pSPRC_Ec234-I) plasmid, while contig 3 represented
a 85,199nt long IncFII_2 (pSPRC_Ec234-FII) plasmid.
The isolate also had two small plasmids. One of these,
pSPRC_Ec234-3 (contig 5; 5164nt), only housed repA
and mobA genes in addition to 3 hypothetical genes.
pSPRC_Ec234-3 displayed 99.7% identity over 100%
of the query sequence with pEc631_5 (CP040268.1)
isolated from an E. coli inhabiting a marine bivalve
mollusc in Norway. There are several other E. coli plas-
mids in GenBank which share ≥99% identity over the
length of pSPRC_Ec234-3 collected from geographi-
cally disparate regions. The second small plasmid
pSPRC_Ec234-4, represented by contig 6 (112.8x cov-
erage), was 2,101nt long and was identical to a Shigella
sonnei Ss046 (pSS046_spC, CP000643.1) plasmid iso-
lated from a patient with bacillary dysentery in
China. Plasmid finder typed it as a ColBS512-like plas-
mid, as the rep gene was identical to S. boydii CDC
3083-94 plasmid pBS512_2 (CP001058.1). Pairwise
alignment of pSPRC_Ec234-4 and pBS512_2 displayed
no sequence similarity across the remaining length of
pBS512_2.
Apart from blaCTX-M-15 that was located on the
chromosome of EC234 (contig 1) adjacent to an
ISEcp1 insertion element and gyrB and parCmutations
that contribute to fluoroquinolone resistance, the
IncFII_2 plasmid pSPRC_Ec234-FII carried most of
the genes that accounted for the phenotypic resistance
profile (Figure 3(A)) of the isolate. Plasmid
pSPRC_Ec234-FII also carried qnrB4 and blaDHA-1 in
close proximity to the CRL. There were four copies
of IS26 in the resistance locus. Two direct copies of
IS26 flanked the locus indicating that it can potentially
function as a translocatable unit. The locus contains
diverse resistance gene cargo including a fragmented
class 1 integron with a dfrA17-aadA5 gene cassette-
array. Notably, both the integrase (intI1) and the ami-
noglycoside resistance (aadA5) genes were interrupted
by copies of IS26. An additional copy of IS26 resides
between the IS6100 associated macrolide resistance
module and the aminoglycoside resistance gene aac
(3)-IIa (encoding resistance to gentamicin and tobra-
mycin). Other features of the resistance loci included
remnants of the 3´-CS of a class 1 integron and the
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blaDHA-1 beta-lactamase gene. BLASTn analysis of
pSPRC_Ec234-FII identified pUB-DHA-1
(MK048477.1) from E. coli strain U-5227, isolated
from human urine, as the closest match in GenBank.
pSPRC_Ec234-FII shared 99.93% identity over 96%
length of pUB-DHA-1, including the cargo of resist-
ance genes. The presence of four copies of IS26 may
enable multiple sections of the resistance locus to inde-
pendently mobilize as translocatable units containing
different combinations of resistance genes [45,46].
IncFII replicons are common features of ST131 gen-
omes [2,15,16,40]. Most phylogenetically related ST131
isolates identified in this study tested positive for IncFII
replicons and had identical resistance cargoes (Figure 2
(B)). We, therefore, verified the presence of
pSPRC_Ec234-FII within closely related ST131 gen-
omes identified in our MrBayes phylogeny analysis
(Figure 3(B)) and in ST131 isolates in our extended col-
lection (Hastak et al Microbial Genomics, 2020). Only
EC233 (the ST8196 representative) had an identical
plasmid. Our read mapping approach indicated the
presence of parts of the plasmid backbone, however,
the plasmid partitioning and stability genes (rep-
resented with light green arrows in the plasmid map
Figure 3(B)) in pSPRC_Ec234-FII are missing in the
other genomes. As such ST8196 isolates carry an
IncFII_2 plasmid, variants of which likely distinguish
them from the population of IncFII plasmids circulat-
ing within E. coli ST131 in Australia. The resistance
cargo present on pSPRC_Ec234-FII has recently been
reported on IncFIA and IncI1 plasmids carried by
ST131 in Australia [47], indicating possible movement
of a compound resistance transposon. pSPRC_Ec234-
FII has a full complement of transfer genes and is likely
laterally mobile, although plasmid mobility was not
tested in this study.
The IncI1 plasmid in EC234, pSPRC_Ec234-I, did
not carry any virulence or resistance genes, however,
it had the full complement of conjugative (type IV
pili) and transfer genes, indicating an ability to
Figure 3. pSPRC_Ec234-FII the IncFII plasmid in EC234. A. Diagrammatic representation of gene content in the IncFII plasmid of
isolate EC234 and the resistance loci in the inset above. Arrows representing gene families are colour coded. Orange arrows:
genes required for plasmid transfer, light green: replication genes, dark green: class 1 integron integrase gene, red arrows: resist-
ance genes, dark blue: insertion elements and purple: hypothetical genes. B. Mapping of raw illumina reads from ST131 in our
collection (upper panel) and EC233_ST8196 and other ST131 isolates identified to be closely related to EC234 from Mr Bayes phy-
logeny analysis (bottom panel).
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mobilize independently and perhaps co-mobilize other
resident plasmids. A BLASTn analysis of
pSPRC_Ec234-I identified pSTM7 (KF290377.1) from
a case of human Salmonellosis linked to pathogenic Sal-
monella Typhimurium strain STm7 in Australia [48] as
the closest match in GenBank. pSPRC_Ec234-I had
99.4% identity but across 73% of the length of
pSTM7. To examine the relative prevalence of IncI1
plasmids similar to pSPRC_Ec234-I in the plasmid
database, 500 completely closed IncI plasmids were
downloaded (23rd September 2019) [49]. A subset of
38 IncI1 plasmids sourced from E. coli, Shigella and Sal-
monella spp. that showed >99% identity over >60% of
the length of pSPRC_Ec234-I, were selected for SNP
phylogeny analysis (Figure 4(A)). Based on the align-
ment of ≥59% of the length of pSPRC_Ec234-I with
the 38 plasmids selected, pSPRC_Ec234-I grouped
with three other IncI1 plasmids, pU12A_B
(NZ_CP035469.1), pU15A_A (NZ_CP035721.1) and
an un-named E. coli plasmid (NZ_LS992187.1). While
pU12A_B and pU15A_A were sourced from E. coli
ST131 isolates recovered from urine samples in Austra-
lia, the E. coli plasmid in NZ_LS992187.1 was reported
from Germany. Considering branch lengths in the SNP
tree, pSPRC_Ec234-I is most closely related to the plas-
mid in the German isolate (NZ_LS992187.1), while the
two Australian plasmids NZ_CP035469.1 and
NZ_CP035721.1 [47] appeared to have accumulated
more SNPS and indels. Alignment of all three plasmids
revealed that the main differences were in the hypothe-
tical genes, while the backbone was fairly conserved,
further supporting the hypothesis that closely related
IncI1 plasmids are circulating in Australia.
Figure 4. Features of IncI1 plasmid pSPRC_Ec234-I in strain EC234. A. Phylogeny of complete IncI1 plasmids available in the plasmid
database. Orange arrows indicate genes required for plasmid transfer and conjugation, green indicates replication genes, red
arrows indicate bacteriocin resistance genes and purple arrows indicate hypothetical genes. B. EasyFig alignment of the three
most closely related plasmids identified in isolate EC234.
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Discussion
Pandemic and high resistance-risk clonal lineages of
extra-intestinal E. coli cause serious problems for
human health globally. We present the first description
of a novel, extensively drug-resistant ExPEC lineage,
ST8196, within the ST131 clonal complex. The two
representative isolates, EC234 and EC233, were col-
lected one day apart from different patients presenting
with bacteraemia at a hospital in Sydney in November
2014 and are characterized by whole genome sequence
analysis in this study. Although the 48 hr post admis-
sion cut-off used to classify hospital-onset and commu-
nity-onset infections can be misleading, the isolates
were collected from two different patients indicating
the presence of the strain in the local community ser-
viced by the hospital. Our phylogenetic analyses pro-
vide compelling evidence that these clonal isolates,
and the ST8196 lineage have most likely evolved in
Australia from the H30Rx sub-lineage of E. coli
ST131 that are circulating locally. Major differences
in ST131 and ST8196 were found primarily in the
accessory genomes. In EC234, the accessory genome
included four completely closed plasmids, an IncFII_2
plasmid pSPRC_Ec234-FII (85,199bp), two small plas-
mids pSPRC_Ec234-3 (5,164bp) and pSPRC_Ec234-4
(2,101bp) and a novel IncI1 plasmid pSPRC_Ec234-I
(92,955bp). The IncFII_2 plasmid pSPRC_Ec234-FII
carries the majority of the resistance gene cargo contri-
buting towards the phenotypic resistance profile and is
likely a variant of IncFII plasmids circulating within
ST131-cladeC2 in Australia [33]. The IncI1 plasmid
pSPRC_Ec234-I in EC234 is likely a progenitor of
IncI1 plasmid lineages reported from ST131 in Austra-
lia [47]. The two IncI1 plasmids reported recently from
Australia pU12A_B (NZ_CP035469.1) and pU15A_A
(NZ_CP035721.1) [47] may have evolved from a com-
mon ancestral IncI1 lineage, raising the possibility that
ST8196 strains EC233 and EC234 acquired
pSPRC_Ec234-I, or a close variant of it, locally.
The dissemination of MDR plasmids within clinical
settings often complicates treatment options. Plasmids
belonging to IncFII incompatibility groups and their
variants are well established in ST131 populations
globally [2, 33]. These plasmids frequently carry allelic
variants of blaCTX-M gene encoding extended spectrum
β-lactamase (ESBL) enzymes that hydrolyse cephalos-
porins and aztreonam, and co-transfer plasmid-
mediated quinolone and aminoglycoside resistance
[50,51]. The CTX-M family of ESBL enzymes are
classified into different phylogenetic groups [52]
based on amino acid sequence of the peptides encoded
by the respective allelic variant. The CTX-M cluster 1
genes, which include CTX-M-15 allele, is primarily dis-
seminated via IncFII:IncFIA plasmids and sometimes
on IncI plasmids [19]; while the CTX-M cluster 9
genes, including CTX-M-14 and CTX-M-27 are
usually associated with IncHI2 plasmids and some-
times with IncFII [53,54]. In the ST8196 isolates, the
blaCTX-M-15 gene was not associated with any plasmid.
To identify and establish the location of resistance
genes in the genomes, including the blaCTX-M-15 gene,
we assembled EC234 genome using both long read
and short-read sequences. The hybrid assembly of
EC234 resolved four plasmids. All resistance genes
contributing to the resistance profile were found to
cluster within a complex resistance locus flanked by
direct copies of IS26 on IncFII_2 plasmid
pSPRC_Ec234-FII. The IS26 flanked region contained
a qnrB4 quinolone resistance gene and a blaDHA-1 β-
lactamase gene in close proximity to the CRL. The
qnrB4 and blaDHA-1 genes are often linked together
and responsible for the dispersal of plasmid-mediated
quinolone resistance in Enterobacteriaceae [50,55,56].
Genes conferring resistance to extended-spectrum β-
lactam (blaCTX-M-15) and fluoroquinolone (gyrA1AB
and parC1aAB) antibiotics were located on the largest
contig in E. coli ST8196; with blaCTX-M-15 linked to
insertion element ISEcp1. In addition to providing lat-
eral mobility, ISEcpI also provides a strong promoter
for expression of the blaCTX-M-15 gene [54,57]. The
2971bp ISEcp1-blaCTX-M15 module in EC234 is identi-
cal to a module found on various plasmid backbones in
several entries in the GenBank database, however, in
EC234 it is inserted at a unique intergenic region of
the chromosome. The module is flanked by 5bp
(TGATC) direct repeats, indicating a single transposi-
tion event associated with the genomic location.
Although the chromosome in EC234 was not closed
and may have some unresolved chromosomal
configurations, genes contributing to fluoroquinolone
resistance and ESBL production were not located
near scaffold breaks and were identified at identical
locations in previous studies [2,14]. Chromosomal
incorporation of an ISEcp1 associated blaCTX-M-15
gene within fluoroquinolone-resistant E. coli ST131
isolates has previously been reported in members of
the H30Rx subclade [13,15], but the insertion site
identified in the ST8196 isolates is unique.
A recent pangenome analysis on a global collection
of 4071 ST131 isolates predicts the potential of out-
breaks by genetically variable isolates with altered
resistance gene cargoes [14] and highlights the neces-
sity for constant genomic surveillance. Different STs
that cluster together into clonal complexes (CC) com-
prise such genetically similar isolates which are charac-
terized by a single change in the allelic profile of the
target genes defining the central MLST genotype [20].
While ST131 continues to be the focus of many geno-
mic and epidemiological studies, there is an underap-
preciation of other STs within the ST131CC. Our
data highlights the near identity of ST8196 isolates
with strains in ST131-H30Rx subclade. The acquisition
of IncI1 and the small cryptic plasmids by ST8196
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identified in the course of this study appears to have
contributed to the evolution of this ST within the
ST131CC. Our study also unravels the phylogenetic
relationship of different STs within the “ST131-clonal
complex” which cluster with representatives of the
three well known ST131 clades; and identifies 43 other
STs within ST131CC that are closely related to the
ST131-clade C representatives. They are therefore
worth exploring further in terms of phenotype-genotype
correlations and monitoring in the course of genomic
epidemiological studies. ST8196 also appears to be clo-
sely related to E. coli ST8189, identified recently in Aus-
tralia, however, EC233 and EC234 share a more recent
common ancestor with E. coli strain EC70_ST131 iso-
lated from the same Sydney hospital. Based on the
MLST profiles, ST8189 differed from ST131 in the
sequence of mdh (allelic variant number 697) encoding
malate dehydrogenase. Metadata pertaining to the
country from which the ST8196 was isolated was not
available in Enterobase or online. However, it is note-
worthy that currently there are three other representa-
tives of ST8189 in Enterobase, including an isolate
(ESC_OA1826AA, SRR10126950) collected in 2017
from Australia and are worth investigating as they are
also phylogenetically related to the H30Rx subclade.
The proposed evolution of ST8189 is based on an
extensive phylogenetic analysis of the core genome and
is supported by pangenome analysis. Our data suggests
that the ST8196 isolates described here evolved from
the H30Rx subclade of ST131 and are armed with viru-
lence attributes and antimicrobial resistance gene cargo
that may contribute to the local establishment of these
clones. In addition, the presence of multiple copies of
IS26within the resistance locus suggests thatnewgenetic
cargo mobilized by IS26 can be readily acquired, and
existing resistance cargo can be passed to other lineages
within the Enterobacteriales. ST8196 isolates have the
potential to cause disease with significantly curtailed
treatment options. We identify 44 STs within the
ST131CC that are closely related to the globally domi-
nant ST131-Clade C strains, highlighting the necessity
of improved characterization of these clinically impor-
tant E. coli lineages. Our study emphasizes the impor-
tance of unbiased genomic surveillance for detecting
novel, MDR ExPEC circulating in the community and
which may ultimately present at health care facilities.
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